Metallo-β-lactamase-producing Pseudomonas aeruginosa Isolates from Two Tertiary Care Centres in a District of Nepal: A Descriptive Cross-sectional Study
Journal of Nepal Medical Association · 2024
DOI: 10.31729/jnma.8498 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Journal of Nepal Medical Association, 2024. Verfasst von Pushpa Man Shrestha und 6 weiteren Autor:innen. Beteiligte Einrichtung: Tribhuvan University, Kirtipur, Kathmandu, Nepal. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, beta-Lactamases, Tertiary Care Centers, Pseudomonas Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Pseudomonas aeruginosa isolates producing metallo-β-lactamase have caused nosocomial outbreaks, severe infections, and ineffective carbapenem therapy worldwide since 1991. Due to their prevalence, hospital infection control techniques are difficult. This study aimed to find out the prevalence of metallo-β-lactamase among P. aeruginosa isolates from two tertiary care hospitals in Kathmandu.
Methods
A descriptive cross-sectional study was conducted at the Department of Microbiology and Department of Pathology of two tertiary care centres in Kathmandu from 7 December 2021 to 6 April 2023, after receiving ethical approval from the Ethical Review Board. Isolated strains were identified and tested for antibiotic susceptibility by modified Kirby-Bauer Methods. Metallo-β-lactamase presence was confirmed using an imipenem-imipenem/ ethylenediaminetetraacetic acid disc. A convenience sampling method was used. The point estimate was calculated at 95% Confidence Interval.
Results
Among 255, Pseudomanas aeruginosa isolates, the distribution of metallo-β-lactamase-producing Pseudomanas aeruginosa was 103 (40.39%) (34.32-46.69 at 95% Confidence Interval). Multidrug resistance categories included multidrug resistance 74 (71.80%), extensively drug resistance 32 (31.10%), P. aeruginosa difficult-to-treat 16 (15.53%) and carbapenem-resistant P. aeruginosa was determined to be 82 (79.60%).
Conclusions
The study found a high prevalence of metallo-β-lactamase-producing Pseudomanas aeruginosa isolates, requiring early identification, infection control measures, and an all-inclusive antimicrobial therapy protocol to reduce their spread in medical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tribhuvan University, Kirtipur, Kathmandu, Nepal.
- Maharajgunj Medical Campus, Maharajgunj, Kathmandu, Nepal.
- National Academy of Medical Sciences, Bir Hospital, Mahabaudha, Kathmandu, Nepal.
Zitieren
APA
Shrestha, P. M., Kattel, H. P., Sharma, S., Bista, P., Basnet, B. K., Ghimire, P., & Rijal, K. R. (2024). Metallo-β-lactamase-producing Pseudomonas aeruginosa Isolates from Two Tertiary Care Centres in a District of Nepal: A Descriptive Cross-sectional Study. Journal of Nepal Medical Association. https://doi.org/10.31729/jnma.8498
Vancouver
Shrestha PM, Kattel HP, Sharma S, Bista P, Basnet BK, Ghimire P, et al. Metallo-β-lactamase-producing Pseudomonas aeruginosa Isolates from Two Tertiary Care Centres in a District of Nepal: A Descriptive Cross-sectional Study. Journal of Nepal Medical Association. 2024. doi:10.31729/jnma.8498
BibTeX
@article{Shrestha2024,
author = {Shrestha, Pushpa Man and Kattel, Hari Prasad and Sharma, Sangita and Bista, Pratibha and Basnet, Bhupendra Kumar and Ghimire, Prakash and Rijal, Komal Raj},
title = {Metallo-β-lactamase-producing Pseudomonas aeruginosa Isolates from Two Tertiary Care Centres in a District of Nepal: A Descriptive Cross-sectional Study},
journal = {Journal of Nepal Medical Association},
year = {2024},
doi = {10.31729/jnma.8498}
}
EUVIMED